$SLAB
Silicon Laboratories Inc

2021 Q2 Form 10-Q Financial Statement

#000110465921056134 Filed on April 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q2
Revenue $157.9M
YoY Change -26.54%
Cost Of Revenue $66.10M
YoY Change -22.87%
Gross Profit $91.75M
YoY Change -28.98%
Gross Profit Margin 58.12%
Selling, General & Admin $42.45M
YoY Change -21.38%
% of Gross Profit 46.27%
Research & Development $64.02M
YoY Change -10.09%
% of Gross Profit 69.77%
Depreciation & Amortization $4.108M
YoY Change -70.66%
% of Gross Profit 4.48%
Operating Expenses $106.5M
YoY Change -14.96%
Operating Profit -$14.72M
YoY Change -467.88%
Interest Expense $11.32M
YoY Change -592.35%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$24.89M
YoY Change -1564.12%
Income Tax $2.000M
% Of Pretax Income
Net Earnings $13.51M
YoY Change 514.05%
Net Earnings / Revenue 8.56%
Basic Earnings Per Share $0.31
Diluted Earnings Per Share $0.29
COMMON SHARES
Basic Shares Outstanding 44.16M
Diluted Shares Outstanding 45.83M

Balance Sheet

Concept 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $572.9M
YoY Change -45.87%
Cash & Equivalents $205.2M
Short-Term Investments $367.7M
Other Short-Term Assets $105.1M
YoY Change 123.62%
Inventory $79.24M
Prepaid Expenses
Receivables $103.7M
Other Receivables $0.00
Total Short-Term Assets $860.9M
YoY Change -31.02%
LONG-TERM ASSETS
Property, Plant & Equipment $141.0M
YoY Change 3.38%
Goodwill $631.9M
YoY Change 58.62%
Intangibles $154.4M
YoY Change 23.9%
Long-Term Investments
YoY Change
Other Assets $82.38M
YoY Change 29.43%
Total Long-Term Assets $1.010B
YoY Change 39.64%
TOTAL ASSETS
Total Short-Term Assets $860.9M
Total Long-Term Assets $1.010B
Total Assets $1.871B
YoY Change -5.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.00M
YoY Change 63.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $150.8M
YoY Change -66.24%
LONG-TERM LIABILITIES
Long-Term Debt $434.3M
YoY Change 16.75%
Other Long-Term Liabilities $78.60M
YoY Change 48.86%
Total Long-Term Liabilities $512.9M
YoY Change 20.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $150.8M
Total Long-Term Liabilities $512.9M
Total Liabilities $663.6M
YoY Change -23.85%
SHAREHOLDERS EQUITY
Retained Earnings $1.007B
YoY Change 2.42%
Common Stock $199.6M
YoY Change 71.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.207B
YoY Change
Total Liabilities & Shareholders Equity $1.871B
YoY Change -5.1%

Cashflow Statement

Concept 2021 Q2
OPERATING ACTIVITIES
Net Income $13.51M
YoY Change 514.05%
Depreciation, Depletion And Amortization $4.108M
YoY Change -70.66%
Cash From Operating Activities $14.51M
YoY Change -75.7%
INVESTING ACTIVITIES
Capital Expenditures $5.705M
YoY Change -239.15%
Acquisitions
YoY Change
Other Investing Activities $152.6M
YoY Change 174.46%
Cash From Investing Activities $146.4M
YoY Change 184.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $140.6M
YoY Change
Cash From Financing Activities -158.4M
YoY Change -157.1%
NET CHANGE
Cash From Operating Activities 14.51M
Cash From Investing Activities 146.4M
Cash From Financing Activities -158.4M
Net Change In Cash 2.504M
YoY Change -99.36%
FREE CASH FLOW
Cash From Operating Activities $14.51M
Capital Expenditures $5.705M
Free Cash Flow $8.801M
YoY Change -86.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001038074
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43925000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44749000
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-03
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-03
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
000-29823
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
SILICON LABORATORIES INC.
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
74-2793174
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
400 West Cesar Chavez
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78701
CY2021Q2 dei City Area Code
CityAreaCode
512
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
416-8500
CY2021Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
205224000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202720000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
367708000
CY2021Q2 dei Trading Symbol
TradingSymbol
SLAB
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44748946
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
521963000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
103699000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95169000
CY2021Q2 us-gaap Inventory Net
InventoryNet
79244000
CY2021Q1 us-gaap Inventory Net
InventoryNet
66662000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
105056000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
89307000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
860931000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
975821000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
141000000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
139439000
CY2021Q2 us-gaap Goodwill
Goodwill
631932000
CY2021Q1 us-gaap Goodwill
Goodwill
631932000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
154379000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
166084000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82381000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80211000
CY2021Q2 us-gaap Assets
Assets
1870623000
CY2021Q1 us-gaap Assets
Assets
1993487000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
68998000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
54949000
CY2021Q1 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
134480000
CY2021Q2 slab Deferred Revenue And Returns Liability Current
DeferredRevenueAndReturnsLiabilityCurrent
13450000
CY2021Q1 slab Deferred Revenue And Returns Liability Current
DeferredRevenueAndReturnsLiabilityCurrent
12986000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
68351000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
82083000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
150799000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
284498000
CY2021Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
434288000
CY2021Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
428945000
CY2021Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
78557000
CY2021Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
80203000
CY2021Q2 us-gaap Liabilities
Liabilities
663644000
CY2021Q1 us-gaap Liabilities
Liabilities
793646000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44749000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43925000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
199576000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
204359000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1007173000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
993664000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
226000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1814000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1206979000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1199841000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1870623000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1993487000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
255505000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214877000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
104922000
us-gaap Cost Of Revenue
CostOfRevenue
85711000
CY2021Q2 us-gaap Gross Profit
GrossProfit
150583000
us-gaap Gross Profit
GrossProfit
129166000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
76474000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71223000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51950000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53996000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
128424000
us-gaap Operating Expenses
OperatingExpenses
125219000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22159000
us-gaap Operating Income Loss
OperatingIncomeLoss
3947000
CY2021Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2875000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
3251000
CY2021Q2 us-gaap Interest Expense
InterestExpense
11324000
us-gaap Interest Expense
InterestExpense
5541000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13710000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1657000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
201000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-587000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13509000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2244000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44160000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43642000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45832000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44388000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13509000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2244000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-836000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-469000
CY2021Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
358000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
100000
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-657000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-809000
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
159000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-141000
CY2021Q2 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-2010000
us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-1237000
CY2021Q2 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-422000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-260000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1588000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-977000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11921000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1267000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1199841000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13509000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1588000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-17817000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13782000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
-748000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1206979000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1115051000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2244000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-977000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-16294000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
16287000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15341000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1099603000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
13509000
us-gaap Profit Loss
ProfitLoss
2244000
CY2021Q2 us-gaap Depreciation
Depreciation
4529000
us-gaap Depreciation
Depreciation
4183000
CY2021Q2 slab Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
11705000
slab Amortization Of Intangibles And Other Assets
AmortizationOfIntangiblesAndOtherAssets
9827000
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
6456000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3736000
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3370000
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13826000
us-gaap Share Based Compensation
ShareBasedCompensation
15313000
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-3197000
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2364000
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8530000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1542000
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12626000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4777000
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
13621000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-23576000
CY2021Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14116000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2748000
CY2021Q2 slab Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
-13429000
slab Increase Decrease In Other Current Liabilities And Income Taxes
IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes
-9134000
CY2021Q2 slab Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
464000
slab Increase Decrease In Deferred Revenue And Returns Liability
IncreaseDecreaseInDeferredRevenueAndReturnsLiability
4114000
CY2021Q2 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-2066000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-862000
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14506000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59700000
CY2021Q2 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
8251000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
70910000
CY2021Q2 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
161392000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
126920000
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6176000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4135000
CY2021Q2 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
578000
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
370000
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
146387000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51505000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
310000000
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
140572000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16287000
CY2021Q2 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17817000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16294000
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-158389000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
277419000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2504000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
388624000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202720000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227146000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
205224000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
615770000
CY2021Q2 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P364D
CY2021 us-gaap Fiscal Period Duration
FiscalPeriodDuration
P371D
CY2021Q2 slab Number Of Days In Fiscal Quarter52 Week Year
NumberOfDaysInFiscalQuarter52WeekYear
P91D
CY2021Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">Use of Estimates</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:14.4pt;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p>
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
270863000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
271720000
CY2021Q2 slab Available For Sale Securities Debt Maturities After One Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTenYearsAmortizedCost
151369000
CY2021Q2 slab Available For Sale Securities Debt Maturities After One Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTenYearsFairValue
151669000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
18800000
CY2021Q2 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
18062000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13509000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2244000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44160000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43642000
CY2021Q2 slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
1672000
slab Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities
IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities
746000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45832000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44388000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2021Q2 slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
1100000
slab Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod
300000
CY2021Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1665000
CY2021Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
441032000
CY2021Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
441451000
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
66261000
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
62000
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
5262000
CY2021Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
738000
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
71523000
CY2021Q2 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
800000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
62055000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
79000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
5340000
CY2021Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
660000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
67395000
CY2021Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
739000
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
68747000
CY2021Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
56165000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10497000
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10497000
CY2021Q2 us-gaap Inventory Net
InventoryNet
79244000
CY2021Q1 us-gaap Inventory Net
InventoryNet
66662000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
255505000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214877000
CY2021Q2 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
12000000.0
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
11100000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
255505000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
214877000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13826000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15313000
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1366000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12161000
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
13947000
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
66000000.0
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.015
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.354
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3200000
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2500000

Files In Submission

Name View Source Status
0001104659-21-056134-index-headers.html Edgar Link pending
0001104659-21-056134-index.html Edgar Link pending
0001104659-21-056134.txt Edgar Link pending
0001104659-21-056134-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slab-20210403.xsd Edgar Link pending
slab-20210403x10q.htm Edgar Link pending
slab-20210403x10q_htm.xml Edgar Link completed
slab-20210403xex31d1.htm Edgar Link pending
slab-20210403xex31d2.htm Edgar Link pending
slab-20210403xex32d1.htm Edgar Link pending
slab-20210403_cal.xml Edgar Link unprocessable
slab-20210403_def.xml Edgar Link unprocessable
slab-20210403_lab.xml Edgar Link unprocessable
slab-20210403_pre.xml Edgar Link unprocessable